Depila Pharmaceuticals Pvt Ltd - Company Profile

It is a public administration private limited company based in Na, Gujarat, India, established in 1989.
1989 Na, Gujarat, India Under Liquidation
Last Updated:
Access Report
About Depila Pharmaceuticals Pvt Ltd

Depila Pharmaceuticals Pvt Ltd, a under liquidation private limited company, was established on 19 October 1989 in Na, Gujarat, India. Engaging in extra territorial organizations within the public administration sector, it holds CIN: U99999GJ1989PTC012897. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M.

It holds ₹11.37 Cr open charges and no settled loans. It is based at 211\2578,Pratikxa Apts Solahousing Road Navrangpura Ahmedabad., Na, Gujarat.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U99999GJ1989PTC012897

  • Registration Number

    012897

  • Incorporation Date

    19 October 1989

  • Authorized Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Under Liquidation

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Company Age 36 Year, 4 Months
  • Open Charges ₹ 11.37 Cr
Company report

Depila Pharmaceuticals Pvt Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Depila Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Depila Pharmaceuticals Pvt Ltd?

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Depila Pharmaceuticals.

Enhance accessibility to Depila Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Depila Pharmaceuticals revenue growth over time
Depila Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Depila Pharmaceuticals?

Unlock access to Depila Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹113,660,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Corporation Bank : 9.00 Cr
  • Bank Of Baroda : 1.38 Cr
  • Nutan Nagarik Sahakari Bank Ltd. : 0.75 Cr
  • Gujarat State Financial Corporation : 0.24 Cr
Latest Charge Details
Date Lender Amount Status
03 Aug 1998 Corporation Bank ₹3.00 Cr Open
03 Aug 1998 Corporation Bank ₹3.00 Cr Open
11 May 1998 Corporation Bank ₹3.00 Cr Open
07 Feb 1997 Nutan Nagarik Sahakari Bank Ltd. ₹7.50 M Open
17 Oct 1994 Bank Of Baroda ₹7.40 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Depila Pharmaceuticals?

Unlock and access historical data on people associated with Depila Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Depila Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Depila Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Depila Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Corporation Bank of Rs. 30.00 M registered on 03 Aug 1998 with Charge ID 90312697 was modified on 05 Jan 1999. was documented.

  • Charges

    A charge with Corporation Bank of Rs. 30.00 M registered on 11 May 1998 with Charge ID 90316003 was modified on 05 Jan 1999. was recorded as a recent event.

  • Charges

    A charge with Corporation Bank of Rs. 30.00 M registered on 03 Aug 1998 with Charge ID 90316024 was modified on 02 Nov 1998. was recorded as a recent event.

  • Charges

    A charge with Corporation Bank amounted to Rs. 30.00 M with Charge ID 90316024 was registered on 03 Aug 1998. was recorded as a recent event.

  • Charges

    The activity A charge with Corporation Bank amounted to Rs. 30.00 M with Charge ID 90312697 was registered on 03 Aug 1998. was completed.

  • Charges

    A charge with Corporation Bank amounted to Rs. 30.00 M with Charge ID 90316003 was registered on 11 May 1998. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Depila Pharmaceuticals Pvt Ltd?

The CIN of Depila Pharmaceuticals Pvt Ltd is U99999GJ1989PTC012897.

Where is Depila Pharmaceuticals Pvt Ltd headquartered?

Depila Pharmaceuticals Pvt Ltd is headquartered at 211\2578,Pratikxa Apts Solahousing Road Navrangpura Ahmedabad., Na, Gujarat.

When was Depila Pharmaceuticals Pvt Ltd incorporated?

Depila Pharmaceuticals Pvt Ltd was incorporated on 19 October 1989.

What is the primary industry of Depila Pharmaceuticals Pvt Ltd?

The primary industry of Depila Pharmaceuticals Pvt Ltd is Public Administration.

Is Depila Pharmaceuticals Pvt Ltd a listed company?

Depila Pharmaceuticals Pvt Ltd is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available